par Bunel, Valérian 
;Antoine, Marie-Hélène ;Nortier, Joëlle ;Duez, Pierre ;Stévigny, Caroline
Référence Journal of applied toxicology, 34, 12, page (1311-9), DOI 10.1002/jat.2951
Publication Publié, 2014
;Antoine, Marie-Hélène ;Nortier, Joëlle ;Duez, Pierre ;Stévigny, Caroline Référence Journal of applied toxicology, 34, 12, page (1311-9), DOI 10.1002/jat.2951
Publication Publié, 2014
Article révisé par les pairs
| Résumé : | Renal proximal tubular epithelial cells are the main targets of toxic drugs such as cisplatin (CisPt), an alkylating agent indicated for the treatment of solid organ tumors. Current techniques aiming at reducing nephrotoxicity in patients receiving CisPt are still not satisfactory as they can only partially prevent acute kidney injury. New nephroprotective strategies remain to be developed. In the present in vitro study, schizandrin (Schi) and schizandrin B (Schi B), major phytochemicals from Schisandra chinensis (Turcz.) Baill. fruits, were tested on HK-2 cells along four processes that could help alleviate CisPt toxicity. Results indicated that: (i) both Schi and Schi B enhanced cell survival via reducing apoptosis rate; (ii) only Schi showed moderate effects towards modulation of regeneration capacities of healthy cells; (iii) both Schi and Schi B limited extracellular matrix deposition; and (iv) both compounds could help preventing dedifferentiation processes via the β-catenin pathway. Schi and Schi B present promising activities for future development of protective agents against CisPt nephrotoxicity. |
